GREGORI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 7.128
AS - Asia 3.048
EU - Europa 3.028
SA - Sud America 455
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 85
OC - Oceania 10
Totale 14.089
Nazione #
US - Stati Uniti d'America 6.755
SG - Singapore 1.010
CN - Cina 780
IT - Italia 604
DE - Germania 496
HK - Hong Kong 358
RU - Federazione Russa 352
CA - Canada 326
BR - Brasile 324
SE - Svezia 321
VN - Vietnam 306
IE - Irlanda 255
GB - Regno Unito 208
UA - Ucraina 188
IN - India 163
FR - Francia 151
PL - Polonia 94
FI - Finlandia 86
AT - Austria 65
BD - Bangladesh 56
DK - Danimarca 50
TR - Turchia 50
KR - Corea 43
AR - Argentina 41
ZA - Sudafrica 40
IR - Iran 39
IQ - Iraq 38
NL - Olanda 35
JP - Giappone 34
BE - Belgio 30
ID - Indonesia 24
ES - Italia 22
VE - Venezuela 22
MX - Messico 19
EC - Ecuador 18
PK - Pakistan 17
SA - Arabia Saudita 16
PH - Filippine 13
UZ - Uzbekistan 13
CO - Colombia 12
MY - Malesia 12
CL - Cile 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
JO - Giordania 9
PT - Portogallo 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
UY - Uruguay 8
GR - Grecia 7
KE - Kenya 7
MA - Marocco 7
NP - Nepal 7
TW - Taiwan 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
OM - Oman 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
EU - Europa 5
HU - Ungheria 5
JM - Giamaica 5
LT - Lituania 5
TH - Thailandia 5
BG - Bulgaria 4
HN - Honduras 4
PE - Perù 4
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LB - Libano 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
EE - Estonia 2
GE - Georgia 2
LV - Lettonia 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DM - Dominica 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
Totale 13.745
Città #
Ann Arbor 942
Ashburn 680
Singapore 608
Woodbridge 557
San Jose 391
Chandler 339
Hong Kong 333
Fairfield 328
Frankfurt am Main 279
Wilmington 259
Houston 253
Dublin 247
Milan 237
Jacksonville 208
Dearborn 194
Toronto 181
Beijing 141
Seattle 141
New York 132
Santa Clara 131
Cambridge 121
Council Bluffs 113
Los Angeles 98
Dallas 87
Princeton 82
Ho Chi Minh City 79
Chicago 69
Hanoi 69
Kraków 69
Shanghai 68
Nanjing 67
The Dalles 59
Vienna 59
Ottawa 48
Wayne 43
Lachine 39
Lauterbourg 39
São Paulo 39
Hefei 38
Buffalo 34
Helsinki 34
Moscow 34
Altamura 33
Guangzhou 30
Lawrence 30
Dong Ket 29
San Diego 29
Brussels 28
Nanchang 28
Orem 28
Rome 28
Seoul 27
Boardman 25
Tokyo 23
Munich 22
Brooklyn 19
Columbus 19
London 19
Tianjin 19
Chennai 18
Fremont 18
Changsha 17
Hangzhou 17
Johannesburg 17
Phoenix 16
Baghdad 15
Jakarta 15
Montreal 15
Shenyang 15
Warsaw 15
Atlanta 14
Pune 14
Mumbai 13
Rio de Janeiro 13
Stockholm 13
Hebei 12
Kunming 12
Quito 12
Tashkent 12
Andover 11
Manchester 11
Zhengzhou 11
Amsterdam 10
Boston 10
Edmonton 10
New Delhi 10
Philadelphia 10
Grafing 9
Jeddah 9
Jiaxing 9
Jinan 9
Montréal 9
Salt Lake City 9
Turku 9
Washington 9
Brno 8
Caracas 8
Copenhagen 8
Da Nang 8
Denver 8
Totale 8.893
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 766
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 501
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 489
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 484
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 464
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 460
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 457
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 435
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 426
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 417
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 387
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 386
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 362
Curcumin derivatives as new ligands of Aβ peptides 359
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 351
Combinatorial Approaches to Iminosugars as Glycosidase and Glycosyltransferase Inhibitors 326
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 321
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 320
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 319
Fructose-based proline analogues: Exploring the prolyl trans/cis-amide rotamer population in model peptides 309
Synthesis and characterization of a paramagnetic sialic acid conjugate as probe for magnetic resonance applications 292
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 290
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 286
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 286
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 279
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 279
A membrane-bound trehalase from Chironomus riparius larvae: Purification and sensitivity to inhibition 278
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 277
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 273
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 272
Nanomedicine for the treatment of Alzheimer's disease 269
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 264
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 260
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 258
Nanotechnology for neurodegenerative disorders 254
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 253
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 248
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 245
Glycans in Magnetic Resonance Imaging: Determinants of Relaxivity to Smart Agents, and Potential Applications in Biomedicine 237
Nanotechnology for neurodegenerative disorders 222
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 219
Design of nanoparticles for the treatment of brain tumors 209
Totale 14.089
Categoria #
all - tutte 40.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022555 0 0 66 65 22 41 65 49 26 59 62 100
2022/20231.250 133 352 141 134 70 184 18 76 84 10 29 19
2023/2024803 17 35 49 51 108 197 166 38 50 10 10 72
2024/20251.659 94 186 123 62 138 62 106 57 169 261 146 255
2025/20264.167 487 193 354 430 544 216 624 173 312 396 239 199
2026/2027634 92 158 384 0 0 0 0 0 0 0 0 0
Totale 14.089